Independent Results Support the Use of BioCurex Technology for Gastric Cancer
19-Oct-2006 -
BioCurex Inc. announced that a group of scientists led by Dr. So Tsuboi from the Shigei Medical Research Hospital, Japan, have published results on the expression of the receptor for AFP (RECAF) in normal, benign and malignant stomach tissue. The tissue study used a variation of the company's ...
biology
dentistry
Expression
+3